Application Type
Invention
Application SubType
Invention PCT
(10) Registration Number and Date
Status
PUBLISHED/${sta2}
(180) Expiration Date
(20) Filing Number and Date
PH 1/2024/552858 2019.05.17
(40) Publication Number and Date
PH 1/2024/552858
A1
2025.06.23
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
(74) Representative Name
(EN) Sapalo Velez Bundang & Bulilan Law Offices : 11th Flr., Security Bank Centre, 6776 Ayala Avenue, Makati City 1200
(54) Title
(EN) ANTI-MUC1 ANTIBODY-DRUG CONJUGATE
(57) Abstract
(EN)

The present invention pertains to novel antibody drug conjugates (ADC) comprising antiMUC1 antibody. In particular, said ADC showed significant anti-tumor efficacy

(58) Citations
Cited DocumentsReferencesCategoryClaimsCitation Type
2.0US 2012/0128676 A1 (GOLETZ, S. et al.) 24 May 2012 Y 1-40Patent
1.0US 2015/0005474 A1 (GOLETZ, S. et al.) 01 January 2015 Y 1-40Patent
3.0Antibody-Specific Model of Amino Acid Substitution for Immunological Inferences from Alignments of Antibody Sequences. Mol Biol Evol. 2015 Mar;32(3):806-19. doi: 10.1093/molbev/msu340. (MIRSKY, A. et al.) 21 December 2014 Y 1-40Patent
Document Type Date Action
Event NameDateStatus
Filing2019.05.17Filed
PCT National Phase Entry2024.11.27PCT National Phase
Publication2025.06.23PUBLISHED
Publication2025.06.27PUBLISHED